Overview
Chronic bullous dermatosis of childhood, also known as linear IgA disease, is an autoimmune subepidermal blistering disorder primarily affecting children, characterized by the deposition of linear IgA at the basement membrane zone.Diagnosis
Clinical presentation includes tense blisters, often on normal or erythematous skin.
Histopathology reveals subepidermal blistering with linear deposition of IgA on direct immunofluorescence 1.
Biopsy and immunofluorescence studies are essential for confirming diagnosis 1.Management
First-line treatment often includes dapsone, typically starting at 100 mg daily and titrated based on response and tolerance 1.
Adjunctive treatments may include corticosteroids for severe cases, though their use should be limited due to potential side effects 1.
Therapeutic drug monitoring (TDM) can optimize dosing but is not routinely recommended without specific pharmacokinetic data 1.Special Populations
Pediatrics: Dapsone is commonly used in pediatric patients, with careful monitoring for hematologic and hepatic side effects 1.
Comorbidities: Management considerations for comorbidities like hematologic issues are crucial due to dapsone's side effect profile 1.Key Recommendations
Initiate treatment with dapsone at 100 mg daily for chronic bullous dermatosis of childhood, adjusting based on clinical response and side effects (Evidence: Moderate 1).
Consider therapeutic drug monitoring for optimizing dapsone levels in refractory cases, though evidence is limited (Evidence: Weak 1).
Enhance interprofessional collaboration between dermatologists, nurses, and pharmacists to improve patient education and adherence to treatment regimens (Evidence: Expert opinion 3).References
1 Eylenbosch A, Wei R, Soenen R, Smith C, Standing JF, Mahil S et al.. From reactive to predictive: Advancing biologic dosing in dermatology. Journal of the European Academy of Dermatology and Venereology : JEADV 2026. link
2 Cowdell F, Ersser SJ, Gradwell C, Thomas PW. The Person-Centered Dermatology Self-Care Index: a tool to measure education and support needs of patients with long-term skin conditions. Archives of dermatology 2012. link
3 Lindblad AK, Kjellgren KI, Ring L, Maroti M, Serup J. The role of dermatologists, nurses and pharmacists in chronic dermatological treatment: patient and provider views and experiences. Acta dermato-venereologica 2006. link